News & Views
Biopharmaceutical Expert Joins Sartorius
Dec 03 2010
Dr Christel Fenge has joined the Sartorius Stedim Biotech group as Vice President of Marketing for Fermentation Technologies. She is globally responsible for managing the product portfolio of multi- and single-use bioreactors, which is said to currently represent the most comprehensive range in the industry.
Most recently Christel was General Manager of Recipharm Biologics and previous posts included senior management positions in biopharmaceutical development at AstraZeneca. She has doctorate in
Biochemistry from the University of Hanover, Germany.
“We are extremely pleased to have Dr Fenge join our organisation to strengthen our Fermentation Technology activities, particularly with regard to implementing and supporting our single-use technology
approach (in which) she will play an essential role,” explained Reinhard Vogt, Member of the Board of Sartorius Stedim Biotech. “She brings with her an exceptional experience base of cell culture and protein science, which will further our customer support and technology bases.”
Digital Edition
Lab Asia 31.4 August 2024
August 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers Labo...
View all digital editions
Events
Sep 04 2024 Chiba, Tokyo, Japan
Sep 04 2024 University of Warwick, Coventry, UK
Sep 11 2024 Bangkok, Thailand
Sep 11 2024 Singapore
Sep 11 2024 Bangkok, Thailand